MINIMAL HEPATIC ENCEPHALOPATHY WITH CIRRHOSIS OF THE LIVER: EFFICIENCY OF TREATMENT AND A POSSIBILITY TO PREDICT THE COURSE OF THE DISEASE. 12-MONTH FOLLOW-UP RESULTS
This study is focused on efficiency of various rifaximin-α regimens in order to optimize the treatment and preventive approaches for cirrhosis of the liver with minimal hepatic encephalopathy, as well as to predict the course of the disease and the risk of complications.
Authors
- I. BAKULIN
- K. IVANOVA
Institutions
- North-Western State Medical University named after I.I. Mechnikov (RU)
- St Peter's Hospital (US)
Publication Details
- Journal
- Медицинский вестник МВД
- Published
- 2024-12-24
- DOI
- https://doi.org/10.52341/20738080_2024_133_6_23
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00